Holdings of THE HARTFORD HEALTHCARE FUND
HARTFORD MUTUAL FUNDS, INC · Original filing · Compare with another fund · Report an error
- Net assets
- 772.2M $ including 757.7M $ in equities, 98.1 %
- Positions
- 77 in 9 countries
- Top ten
- 47.7 % of net assets
- Filed on
- Jul 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 80,883 | 92.9M $ | 12.03 % |
| 2 | Johnson & Johnson | 203,265 | 52.1M $ | 6.75 % |
| 3 | Merck & Co Inc | 355,648 | 46.3M $ | 6.00 % |
| 4 | UnitedHealth Group Inc | 88,244 | 36.6M $ | 4.74 % |
| 5 | AbbVie Inc | 129,664 | 32.5M $ | 4.21 % |
| 6 | Elevance Health Inc | 61,615 | 23.2M $ | 3.00 % |
| 7 | Intuitive Surgical Inc | 62,861 | 22.2M $ | 2.88 % |
| 8 | CVS Health Corp | 210,042 | 21.9M $ | 2.84 % |
| 9 | Vertex Pharmaceuticals Inc | 42,701 | 20.4M $ | 2.64 % |
| 10 | Danaher Corp | 101,835 | 19.9M $ | 2.57 % |
| 11 | Edwards Lifesciences Corp | 222,690 | 19.2M $ | 2.48 % |
| 12 | Cencora Inc | 61,017 | 19M $ | 2.46 % |
| 13 | Regeneron Pharmaceuticals Inc | 20,444 | 15.6M $ | 2.02 % |
| 14 | HCA Healthcare Inc | 36,047 | 14.5M $ | 1.88 % |
| 15 | Boston Scientific Corp | 310,388 | 14.5M $ | 1.88 % |
| 16 | Abbott Laboratories | 133,195 | 14.1M $ | 1.82 % |
| 17 | Thermo Fisher Scientific Inc | 21,279 | 12.2M $ | 1.58 % |
| 18 | Agilent Technologies Inc | 85,848 | 11.9M $ | 1.54 % |
| 19 | Amgen Inc | 27,841 | 10.7M $ | 1.39 % |
| 20 | Biogen Inc | 51,870 | 10.5M $ | 1.36 % |
| 21 | Stryker Corp | 29,293 | 9.5M $ | 1.24 % |
| 22 | GSK PLC | 346,649 | 9M $ | 1.17 % |
| 23 | Medtronic PLC | 101,577 | 8.7M $ | 1.12 % |
| 24 | Centene Corp | 136,277 | 8.5M $ | 1.10 % |
| 25 | Dexcom Inc | 93,874 | 7.8M $ | 1.01 % |
| 26 | Incyte Corp | 61,086 | 7.3M $ | 0.95 % |
| 27 | Cardinal Health Inc | 30,813 | 7.1M $ | 0.92 % |
| 28 | United Therapeutics Corp | 13,024 | 6.7M $ | 0.87 % |
| 29 | STERIS PLC | 28,649 | 6.5M $ | 0.85 % |
| 30 | UCB SA | 23,685 | 6.1M $ | 0.79 % |
| 31 | AstraZeneca PLC | 35,800 | 6.1M $ | 0.79 % |
| 32 | Ascendis Pharma A/S | 23,901 | 5.8M $ | 0.75 % |
| 33 | Bristol-Myers Squibb Co | 88,181 | 5.8M $ | 0.75 % |
| 34 | ELANCO ANIMAL HEALTH INC | 215,158 | 5.7M $ | 0.73 % |
| 35 | CYTOKINETICS INC | 72,039 | 5.6M $ | 0.72 % |
| 36 | Madrigal Pharmaceuticals Inc | 11,677 | 5.5M $ | 0.71 % |
| 37 | IONIS PHARMACEUTICALS INC | 104,043 | 5.4M $ | 0.70 % |
| 38 | Galderma Group AG | 24,060 | 5.2M $ | 0.68 % |
| 39 | ALNYLAM PHARMACEUTICALS INC | 24,864 | 5.1M $ | 0.66 % |
| 40 | REVOLUTION MEDICINES INC | 26,888 | 5M $ | 0.65 % |
| 41 | Protagonist Therapeutics Inc | 35,155 | 4.8M $ | 0.62 % |
| 42 | PTC Therapeutics Inc | 68,186 | 4.6M $ | 0.60 % |
| 43 | HeartFlow Inc | 182,088 | 4.6M $ | 0.59 % |
| 44 | Bridgebio Pharma Inc | 57,222 | 4.6M $ | 0.59 % |
| 45 | ARCUS BIOSCIENCES INC | 160,316 | 4.5M $ | 0.59 % |
| 46 | Disc Medicine Inc | 55,907 | 4.3M $ | 0.56 % |
| 47 | Argenx SE | 4,871 | 4.2M $ | 0.54 % |
| 48 | Encompass Health Corp | 37,246 | 4.1M $ | 0.54 % |
| 49 | Pharvaris NV | 123,487 | 4M $ | 0.52 % |
| 50 | KYMERA THERAPEUTICS INC | 38,652 | 4M $ | 0.52 % |
| 51 | Celldex Therapeutics Inc | 104,861 | 4M $ | 0.52 % |
| 52 | Dianthus Therapeutics Inc | 37,237 | 4M $ | 0.52 % |
| 53 | STRUCTURE THERAPEUTICS INC | 79,359 | 3.8M $ | 0.49 % |
| 54 | Scholar Rock Holding Corp | 77,842 | 3.7M $ | 0.48 % |
| 55 | Immunocore Holdings PLC | 108,668 | 3.7M $ | 0.48 % |
| 56 | Adaptive Biotechnologies Corp | 159,983 | 3.6M $ | 0.47 % |
| 57 | Option Care Health Inc | 150,929 | 3.5M $ | 0.45 % |
| 58 | ZENAS BIOPHARMA INC | 108,627 | 3.4M $ | 0.44 % |
| 59 | MIRUM PHARMACEUTICALS INC | 31,231 | 3.3M $ | 0.43 % |
| 60 | VAXCYTE INC | 58,543 | 3.2M $ | 0.41 % |
| 61 | QIAGEN NV | 74,691 | 3.1M $ | 0.40 % |
| 62 | Immunome Inc | 135,852 | 3.1M $ | 0.40 % |
| 63 | CG ONCOLOGY INC | 40,863 | 2.9M $ | 0.38 % |
| 64 | Trevi Therapeutics Inc | 155,503 | 2.8M $ | 0.37 % |
| 65 | Inspire Medical Systems Inc | 51,992 | 2.6M $ | 0.34 % |
| 66 | Stoke Therapeutics Inc | 89,171 | 2.6M $ | 0.33 % |
| 67 | JIANGSU HENGRUI PHARMACEUTICALS CO LTD | 317,981 | 2.3M $ | 0.30 % |
| 68 | Kailera Therapeutics Inc | 133,356 | 2.3M $ | 0.29 % |
| 69 | MODERNA INC | 40,629 | 2.2M $ | 0.29 % |
| 70 | Definium Therapeutics Inc | 49,500 | 2.2M $ | 0.28 % |
| 71 | DYNE THERAPEUTICS INC | 85,300 | 2.1M $ | 0.28 % |
| 72 | GenFleet Therapeutics Shanghai Inc | 583,800 | 2.1M $ | 0.27 % |
| 73 | ALIGNMENT HEALTHCARE INC | 130,758 | 1.9M $ | 0.25 % |
| 74 | ICON PLC | 11,852 | 1.9M $ | 0.25 % |
| 75 | AVALYN PHARMA INC | 17,700 | 509.6K $ | 0.07 % |
| 76 | Alebund Pharmaceuticals Jiangsu Ltd | 85,600 | 297.3K $ | 0.04 % |
| 77 | Alamar Biosciences Inc | 9,100 | 230.8K $ | 0.03 % |
Sector breakdown
- Health care 80.1 %
- Unattributed 19.9 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 96.7 %
- GBP 1.2 %
- EUR 0.8 %
- CHF 0.7 %
- HKD 0.6 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 93.8 %
- United Kingdom 2.0 %
- Netherlands 1.1 %
- Belgium 0.8 %
- Denmark 0.8 %
- Switzerland 0.7 %
- Hong Kong SAR China 0.6 %
- Ireland 0.3 %
- China 0.0 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 66 | 710.6M $ | 93.79 % |
| 2 | United Kingdom | 2 | 15.1M $ | 1.99 % |
| 3 | Netherlands | 2 | 8.2M $ | 1.08 % |
| 4 | Belgium | 1 | 6.1M $ | 0.80 % |
| 5 | Denmark | 1 | 5.8M $ | 0.77 % |
| 6 | Switzerland | 1 | 5.2M $ | 0.69 % |
| 7 | Hong Kong SAR China | 2 | 4.4M $ | 0.58 % |
| 8 | Ireland | 1 | 1.9M $ | 0.26 % |
| 9 | China | 1 | 297.3K $ | 0.04 % |
Cite this page
Titelia. "Holdings of THE HARTFORD HEALTHCARE FUND". https://titelia.com/en/funds/S000003576